Tesamorelin/Ipamorelin

Description

Tesamorelin/Ipamorelin (1:1)
Double the Signal. Dial In Growth. Target Fat with Precision.

This 1:1 blend of Tesamorelin and Ipamorelin is designed for researchers exploring endogenous GH stimulation with enhanced specificity, metabolic impact, and recovery potential—without overstimulating unwanted pathways.
Tesamorelin, a stabilized analog of GHRH, offers longer half-life and consistent pituitary signaling, while Ipamorelin, a selective GHSR agonist, promotes clean, pulse-driven GH release. Together, they allow labs to model growth hormone optimization, visceral fat loss, and anabolic recovery in a tightly controlled format.

Researchers study this blend for:
⚡️ Endogenous GH release and IGF-1 elevation
⚡️ Reduction of visceral adipose tissue (VAT)
⚡️ Recovery, regeneration, and lean mass preservation
⚡️ Pituitary + ghrelin receptor synergy without cortisol spikes
This combo supports research into GH-driven body composition changes, while avoiding the noise of exogenous hormone interventions.

Product Details:
Components: Tesamorelin / Ipamorelin (1:1 ratio)
CAS Numbers: Tesamorelin: 218949-48-5 | Ipamorelin: 170851-70-4
Form: Lyophilized peptide blend (Receptor Grade)
Storage: Store in a cool, dry place. Refrigerate or freeze for long-term use. Avoid repeated freeze-thaw cycles.

⚠️ Research Use Only
This blend is sold strictly for laboratory research use only. This product is not FDA-approved and is not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are a qualified researcher or lab professional conducting studies in accordance with applicable laws.